Echinacea for treating the common cold a randomized trial

Annals of Internal Medicine

Volumn 153, Issue 12, 2010, Pages 769-777

  Barrett, Bruce ^a   Brown, Roger ^b   Rakel, Dave ^a   Mundt, Marlon ^a   Bone, Kerry ^c   Barlow, Shari ^a   Ewers, Tola ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

^c Research and Development   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ECHINACEA EXTRACT; INTERLEUKIN 8; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DRUG INDUCED HEADACHE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPHIL COUNT; PATIENT COMPLIANCE; PHYTOCHEMISTRY; PLANT ROOT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SELF REPORT; STOMACH DISEASE; TASTE DISORDER;

EID: 78751606160     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-12-201012210-00003     Document Type: Article

References (74)

1. Gwaltney JM Jr. Virology and immunology of the common cold. Rhinology. 1985;23:265-71. [PMID: 3001912]
2. Monto AS. Viral respiratory infections in the community: epidemiology, agents, and interventions. Am J Med. 1995;99:24S-27S. [PMID: 8585553]
3. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443-50. [PMID: 14749452]
4. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775-85. [PMID: 18230677] (Pubitemid 351451744)
5. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA. 2005;293:987-97. [PMID: 15728170]
6. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5:718-25. [PMID: 16253889]
7. Jefferson T. Influenza. Clin Evid. 2009;1-36.
8. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487-94. [PMID: 12588210] (Pubitemid 36244917)
9. Turner RB. New considerations in the treatment and prevention of rhinovirus infections. Pediatr Ann. 2005;34:53-7. [PMID: 15693216]
10. Flannery MA. From rudbeckia to echinacea: the emergence of the purple cone flower in modern therapeutics. Pharm Hist. 1999;41:52-9. [PMID: 11623947]
11. Bauer R, Wagner H. Echinacea species as potential immunostimulatory drugs. In: Wagner H, Farnsworth NR, eds. Economic and Medicinal Plant Research. New York: Academic Pr; 1991:253-318.
12. Melchart D, Linde K, Worku F, Bauer R, Wagner H. Immunomodulation with Echinacea - a systematic review of controlled trials. Phytomedicine. 1994;1:245-54.
13. Barrett B. Medicinal properties of Echinacea: a critical review. Phytomedicine. 2003;10:66-86. [PMID: 12622467]
14. Barrett B. Echinacea and ginseng for immunomodulation and protection from respiratory infection. PharmacologyOnLine. 2006;3:392-407.
15. Bauer R. Chemistry, analysis and immunological investigations of Echinacea phytopharmaceuticals. In: Wagner H, ed. Immunomodulatory Agents from Plants. Basel, Switzerland: Birkhauser Verlag; 1999:41-88.
16. Block KI, Mead MN. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther. 2003;2:247-67. [PMID: 15035888]
17. Bukovsk M, Vaverkov S, Kost' lov D. Immunomodulating activity of Echinacea gloriosa L., Echinacea angustifolia DC. and Rudbeckia speciosa Wenderoth ethanol-water extracts. Pol J Pharmacol. 1995;47:175-7. [PMID: 8688891]
18. Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R, et al. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. Int Immunopharmacol. 2002;2:381-7. [PMID: 11811940]
19. Guiotto P, Woelkart K, Grabnar I, Voinovich D, Perissutti B, Invernizzi S, et al. Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract. Phytomedicine. 2008;15:547-54. [PMID: 18583121]
20. Wagner H, Stuppner H, Schafer W, Zenk M. Immunologically active polysaccharides of Echinacea purpurea cell cultures. Phytochemistry. 1988;27:119-26.
21. Woelkart K, Bauer R. The role of alkamides as an active principle of echinacea. Planta Med. 2007;73:615-23. [PMID: 17538868] (Pubitemid 47066152)
22. Zhai Z, Haney D, Wu L, Solco A, Murphy PA, Wurtele ES, et al. Alcohol extracts of Echinacea inhibit production of nitric oxide and tumor necrosis factoralpha by macrophages in vitro. Food Agric Immunol. 2007;18:221-236. [PMID: 18458735]
23. Bernath J, Percival SS. The oxidative burst of HL-60 cells is modified differently by individual echinacea species and plant parts. FASEB J. 2001;15:A1228.
24. Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther. 2004;75:89-100. [PMID: 14749695]
25. Jager H, Meinel L, Dietz B, Lapke C, Bauer R, Merkle HP, et al. Transport of alkamides from Echinacea species through Caco-2 monolayers [Letter]. Planta Med. 2002;68:469-71. [PMID: 12058332]
26. Matthias A, Gillam EM, Penman KG, Matovic NJ, Bone KM, De Voss JJ, et al. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes. Chem Biol Interact. 2005;155:62-70. [PMID: 15885678]
27. Woelkart K, Xu W, Pei Y, Makriyannis A, Picone RP, Bauer R. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots. Planta Med. 2005;71:701-5. [PMID: 16142631]
28. Woelkart K, Marth E, Suter A, Schoop R, Raggam RB, Koidl C, et al. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system. Int J Clin Pharmacol Ther. 2006;44:401-8. [PMID: 16995328]
29. Senchina DS, McCann DA, Asp JM, Johnson JA, Cunnick JE, Kaiser MS, et al. Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4 degrees C for four days. Clin Chim Acta. 2005;355:67-82. [PMID: 15820480]
30. American Herbal Pharmacopoeia. Echinacea purpurea Root: Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz, CA: American Herbal Pharmacopoeia; 2004.
31. American Herbal Pharmacopoeia. Echinacea angustifolia Root: Standards of Analysis, Quality Control, and Therapeutics. Scotts Valley, CA: American Herbal Pharmacopoeia and Therapeutic Compendium; 2010.
32. Gertsch J, Schoop R, Kuenzle U, Suter A. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett. 2004;577:563-9. [PMID: 15556647]
33. Hinz B, Woelkart K, Bauer R. Alkamides from Echinacea inhibit cyclooxygenase-2 activity in human neuroglioma cells. Biochem Biophys Res Commun. 2007;360:441-6. [PMID: 17599805]
34. LaLone CA, Hammer KD, Wu L, Bae J, Leyva N, Liu Y, et al. Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells. J Agric Food Chem. 2007;55:7314-22. [PMID: 17696440]
35. Matthias A, Addison RS, Penman KG, Dickinson RG, Bone KM, Lehmann RP. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion. Life Sci. 2005;77:2018-29. [PMID: 15919096] (Pubitemid 41080644)
36. Woelkart K, Dittrich P, Beubler E, Pinl F, Schoop R, Suter A, et al. Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans. Planta Med. 2008;74:651-6. [PMID: 18240099]
37. Woelkart K, Bauer R. The role of alkamides as an active principle of echinacea. Planta Med. 2007;73:615-23. [PMID: 17538868] (Pubitemid 47066152)
38. Zhai Z, Haney D, Wu L, Solco A, Murphy PA, Wurtele ES, et al. Alcohol extracts of Echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro. Food Agric Immunol. 2007;18:221-236. [PMID: 18458735]
39. Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract. 1999;48:628-35. [PMID: 10496642]
40. Giles JT, Palat CT 3rd, Chien SH, Chang ZG, Kennedy DT. Evaluation of echinacea for treatment of the common cold. Pharmacotherapy. 2000;20:690-7. [PMID: 10853625]
41. Barrett BP, Brown RL, Locken K, Maberry R, Bobula JA, D'Alessio D. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002;137:939-46. [PMID: 12484708]
42. Cohen HA, Varsano I, Kahan E, Sarrell EM, Uziel Y. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebocontrolled, multicenter study. Arch Pediatr Adolesc Med. 2004;158:217-21. [PMID: 14993078]
43. Goel V, Lovlin R, Barton R, Lyon MR, Bauer R, Lee TD, et al. Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther. 2004;29:75-83. [PMID: 14748902] (Pubitemid 38253541)
44. Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto AS. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin Infect Dis. 2004;38:1367-71. [PMID: 15156472]
45. Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. 2003;290:2824-30. [PMID: 14657066] (Pubitemid 37509490)
46. Turner RB, Riker DK, Gangemi JD. Ineffectiveness of echinacea for prevention of experimental rhinovirus colds. Antimicrob Agents Chemother. 2000;44:1708-9. [PMID: 10817735]
47. Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med. 2005;353:341-8. [PMID: 16049208]
48. Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2004;164:1237-41. [PMID: 15197051]
49. Caruso TJ, Gwaltney JM Jr. Treatment of the common cold with echinacea: a structured review. Clin Infect Dis. 2005;40:807-10. [PMID: 15736012]
50. Huntley AL, Thompson Coon J, Ernst E. The safety of herbal medicinal products derived from Echinacea species: a systematic review. Drug Saf. 2005;28:387-400. [PMID: 15853441]
51. Linde K, Barrett B, W lkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2006:CD000530. [PMID: 16437427]
52. Schoop R, Klein P, Suter A, Johnston SL. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther. 2006;28:174-83. [PMID: 16678640]
53. Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. 2007;7:473-80. [PMID: 17597571] (Pubitemid 46962345)
54. Barrett B, Rakel D, Chewning B, Marchand L, Rabago D, Brown R, et al. Rationale and methods for a trial assessing placebo, echinacea, and doctor-patient interaction in the common cold. Explore (NY). 2007;3:561-72. [PMID: 18005908]
55. Becker S, Koren HS, Henke DC. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Respir Cell Mol Biol. 1993;8:20-7. [PMID: 8417753]
56. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med. 2000;162:2226-31. [PMID: 11112143] (Pubitemid 32051692)
57. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 1995;171:584-92. [PMID: 7876605]
58. Teran LM, Johnston SL, Schr der JM, Church MK, Holgate ST. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med. 1997;155:1362-6. [PMID: 9105080]
59. Jackson GG, Dowling HF, Muldoon RL. Acute respiratory diseases of viral etiology. VII. Present concepts of the common cold. Am J Public Health Nations Health. 1962;52:940-5. [PMID: 14450587]
60. Barrett B, Brown R, Mundt M, Safdar N, Dye L, Maberry R, et al. The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid. J Clin Epidemiol. 2005;58:609-17. [PMID: 15878475] (Pubitemid 40692727)
61. Barrett B, Brown RL, Mundt MP, Thomas GR, Barlow SK, Highstrom AD, et al. Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21). Health Qual Life Outcomes. 2009;7:76. [PMID: 19674476]
62. Ware JE, Kosinski M, Dewey JE, Gandek B. How to score and interpret single-item health status measures: A manual for users of the SF-8 health survey. Lincoln, RI: QualityMetric; 2001.
63. Badia Llach X, Herdman M, Schiaffino A. Determining correspondence between scores on the EQ-5D "thermometer" and a 5-point categorical rating scale. Med Care. 1999;37:671-7. [PMID: 10424638]
64. Cohen S, Frank E, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM Jr. Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol. 1998;17:214-23. [PMID: 9619470] (Pubitemid 28277114)
65. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-96. [PMID: 6668417]
66. Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapam S, Oskamp S, eds. The Social Psychology of Health: Claremont Symposium on Applied Social Psychology. Newbury Park, CA: Sage; 1988.
67. Ryff CD, Singer B. Psychological well-being: meaning, measurement, and implications for psychotherapy research. Psychother Psychosom. 1996;65:14-23. [PMID: 8838692] (Pubitemid 26041204)
68. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994;67:1063-78. [PMID: 7815302]
69. Little RJ. A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc. 1988;83:1198-202.
70. Schafer JL. Analysis of Incomplete Multivariate Data. London: Chapman & Hall; 1997.
71. McCullagh P, Nelder JA. Generalized Linear Models. London: Chapman & Hall; 1989.
72. Barrett B, Brown R, Mundt M, Dye L, Alt J, Safdar N, et al. Using benefit harm tradeoffs to estimate sufficiently important difference: the case of the common cold. Med Decis Making. 2005;25:47-55. [PMID: 15673581] (Pubitemid 40139883)
73. Barrett B, Harahan B, Brown D, Zhang Z, Brown R. Sufficiently important difference for common cold: severity reduction. Ann Fam Med. 2007;5:216-23. [PMID: 17548849] (Pubitemid 46889998)
74. Barrett B, Brown R, Mundt M. Comparison of anchor-based and distributional approaches in estimating important difference in common cold. Qual Life Res. 2008;17:75-85. [PMID: 18027107]